NASDAQ Composite opens in less than two hours and ImmunoGen‘s pre-market value is already 5.3% up.

The last session, NASDAQ Composite finished with ImmunoGen (IMGN) jumping 1.91% to $6.41. NASDAQ Composite jumped 0.78% to $14,020.33, following the last session’s upward trend on what was a somewhat positive trend exchanging session.


Today’s last reported volume for ImmunoGen is 1356357 which is 33.27% below its average volume of 2032673.

ImmunoGen’s last close was $6.29, 42.19% under its 52-week high of $10.88.

ImmunoGen’s Sales

ImmunoGen’s sales growth is 29.7% for the present quarter and 24.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 28.6% and a negative 53.8%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth grew by 91.2%, now sitting on 132.3M for the twelve trailing months.

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $6.41 at 08:11 EST, way under its 52-week high of $10.88 and way above its 52-week low of $3.38.

ImmunoGen’s Moving Average

ImmunoGen’s value is below its 50-day moving average of $6.87 and way under its 200-day moving average of $7.44.


ImmunoGen’s last day, last week, and last month’s current volatility was 0.32%, 2.07%, and 2.36%, respectively.

ImmunoGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.37% (day), 5.54% (last week), and 5.43% (last month), respectively.

More news about ImmunoGen (IMGN).


Please enter your comment!
Please enter your name here